false statements

Class action lawsuit filed against $ATARA alleging executives misled investors about manufacturing issues and study deficiencies affecting tabelecleucel FDA approval prospects.

Class action lawsuit filed against Grocery Outlet ($GO) alleging securities fraud, false financial statements, and unsustainable expansion strategy from August 2025-March 2026.

Vital Farms faces class action lawsuit alleging securities violations over understated ERP system implementation risks. Deadline May 26, 2026.

Securities class action filed against $PINS over alleged false statements on ad revenues, tariff impacts, and undisclosed restructuring plans. Investors have until May 29, 2026 deadline.

Rosen Law Firm alerts AQST investors of May 4, 2026 deadline to join class action alleging Aquestive Therapeutics concealed human factors issues with its Anaphylm drug application.

Rosen Law Firm alerts $ODD investors of securities class action lawsuit alleging false statements about advertising partner algorithm changes affecting financial strength.

Rosen Law Firm files class action against Babcock & Wilcox over alleged false statements regarding Applied Digital power contract involving controlling shareholder BRC Group.

Class action lawsuit filed against monday.com alleging material misstatements on revenue expansion, growth prospects, and sales cycles from September 2025 to February 2026.

Boston Scientific faces class action lawsuit alleging material misstatements about U.S. electrophysiology segment. Investors from July 2025-February 2026 may have claims; May 4, 2026 deadline to apply as lead plaintiff.

Class action lawsuit filed against $STLA alleging materially false statements on earnings forecasts and electrification strategy between February 2025 and February 2026.

Class action lawsuit filed against Lakeland Industries for allegedly making false statements about business operations and overstating division performance between December 2023 and December 2025.

Rosen Law Firm urges $FBRT investors with $100K+ losses to seek counsel before April 27, 2026 lead plaintiff deadline in securities class action over allegedly false dividend sustainability claims.

ImmunityBio ($IBRX) investors face May 26, 2026 deadline to claim lead plaintiff status in securities lawsuit alleging false statements about Anktiva capabilities and business prospects.

Rosen Law Firm files securities class action against Upstart Holdings ($UPST) over false AI model claims, with lead plaintiff deadline June 8, 2026.

Nektar Therapeutics faces securities class action over alleged REZOLVE-AA trial disclosure failures. Investors who purchased shares February-December 2025 may seek recovery; lead plaintiff deadline is May 5, 2026.

Class action alleges $HTGC misrepresented due diligence and portfolio valuations. Investors must act by May 19, 2026 to join lawsuit.

Securities lawsuit filed against monday.com ($MNDY) alleges false revenue guidance; investors have until May 11, 2026 to serve as lead plaintiff.

Eos Energy investors face May 5, 2026 deadline to join securities class action alleging false production capacity and operational claims that harmed shareholders.

Lakeland Industries investors with $100K+ losses must join securities lawsuit by April 24, 2026, alleging false statements about Pacific Helmets and Jolly businesses.

Rosen Law Firm solicits $SMCI investors for class action alleging false statements about Chinese sales violating export controls. Lead plaintiff deadline: May 26, 2026.